AR068813A1 - DERIVATIVES OF PIRAZOL REPLACED AS ANTAGONISTS OF THE ANDROGEN RECEIVER (AR), A PHARMACEUTICAL AGENT THAT UNDERSTANDS AND USES THEMSELVES IN THE TREATMENT OF PROSTATE CANCER - Google Patents
DERIVATIVES OF PIRAZOL REPLACED AS ANTAGONISTS OF THE ANDROGEN RECEIVER (AR), A PHARMACEUTICAL AGENT THAT UNDERSTANDS AND USES THEMSELVES IN THE TREATMENT OF PROSTATE CANCERInfo
- Publication number
- AR068813A1 AR068813A1 ARP080103710A ARP080103710A AR068813A1 AR 068813 A1 AR068813 A1 AR 068813A1 AR P080103710 A ARP080103710 A AR P080103710A AR P080103710 A ARP080103710 A AR P080103710A AR 068813 A1 AR068813 A1 AR 068813A1
- Authority
- AR
- Argentina
- Prior art keywords
- atom
- group linked
- pirazol
- understands
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Un derivado de pirazol y un antagonista del receptor de androgeno que contiene el derivado. Se proporciona un compuesto representado por la formula (1) en donde R1 es un átomo de hidrogeno, un grupo unido a través de un átomo de carbono, un grupo unido a través de un átomo de nitrogeno, un grupo unido a través de un átomo de oxígeno, o un grupo unido a través de un átomo de azufre; R2 es un grupo fenilo que tiene ciano (el grupo fenilo además puede tener sustituyente(s) diferentes de ciano); R3 es un átomo de hidrogeno, un grupo unido a través de un átomo de carbono, un grupo unido a través de un átomo de nitrogeno, un grupo unido a través de un átomo de oxígeno, o un grupo unido a través de un átomo de azufre; R4 es un grupo cíclico que opcionalmente tiene sustituyente(s); y X es metileno que opcionalmente tiene sustituyente(s), o CO; o una de sus sales.A pyrazole derivative and an androgen receptor antagonist that contains the derivative. A compound represented by the formula (1) is provided in which R 1 is a hydrogen atom, a group linked through a carbon atom, a group linked through a nitrogen atom, a group linked through an atom of oxygen, or a group linked through a sulfur atom; R2 is a phenyl group having cyano (the phenyl group may also have substituents (s) other than cyano); R3 is a hydrogen atom, a group linked through a carbon atom, a group linked through a nitrogen atom, a group linked through an oxygen atom, or a group linked through an atom of sulfur; R4 is a cyclic group that optionally has substituent (s); and X is methylene which optionally has substituent (s), or CO; or one of its salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007224910 | 2007-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR068813A1 true AR068813A1 (en) | 2009-12-09 |
Family
ID=40387261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080103710A AR068813A1 (en) | 2007-08-30 | 2008-08-27 | DERIVATIVES OF PIRAZOL REPLACED AS ANTAGONISTS OF THE ANDROGEN RECEIVER (AR), A PHARMACEUTICAL AGENT THAT UNDERSTANDS AND USES THEMSELVES IN THE TREATMENT OF PROSTATE CANCER |
Country Status (20)
Country | Link |
---|---|
US (2) | US20100227846A1 (en) |
EP (1) | EP2194045A4 (en) |
JP (1) | JPWO2009028543A1 (en) |
KR (1) | KR20100046275A (en) |
CN (1) | CN101842357A (en) |
AR (1) | AR068813A1 (en) |
AU (1) | AU2008292429A1 (en) |
BR (1) | BRPI0816095A2 (en) |
CA (1) | CA2697663A1 (en) |
CL (1) | CL2008002521A1 (en) |
CO (1) | CO6190530A2 (en) |
DO (1) | DOP2010000068A (en) |
EA (1) | EA201070323A1 (en) |
EC (1) | ECSP10010060A (en) |
MA (1) | MA31714B1 (en) |
MX (1) | MX2010002266A (en) |
PE (1) | PE20090610A1 (en) |
TN (1) | TN2010000091A1 (en) |
TW (1) | TW200913993A (en) |
WO (1) | WO2009028543A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2720343A1 (en) * | 2008-04-04 | 2009-10-08 | Takeda Pharmaceutical Company Limited | Heterocyclic derivative and use thereof |
JP2013504531A (en) * | 2009-09-11 | 2013-02-07 | バイエル・ファルマ・アクチェンゲゼルシャフト | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
AR078793A1 (en) | 2009-10-27 | 2011-12-07 | Orion Corp | DERIVATIVES OF NON-STEROID CARBOXAMIDS AND ACIL HYDRAZONE MODULATORS OF ANDROGENIC RECEPTORS OF SELECTIVE FABRIC (SARM), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN THE TREATMENT OF PROSTATE CANCER BETWEEN OTHERS |
US8697911B2 (en) | 2010-07-07 | 2014-04-15 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
US9079880B2 (en) | 2010-07-07 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
WO2012054367A1 (en) | 2010-10-19 | 2012-04-26 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
AU2011318875A1 (en) | 2010-10-22 | 2013-05-02 | Astellas Pharma Inc. | Antagonist for mutated androgen receptor |
US9464079B2 (en) | 2011-03-23 | 2016-10-11 | Semorex Technologies Ltd. | Treatment of proliferative disorders with a chemiluminescent agent |
MX360611B (en) | 2011-04-21 | 2018-11-09 | Orion Corp | Androgen receptor modulating carboxamides. |
US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
US9199975B2 (en) | 2011-09-30 | 2015-12-01 | Asana Biosciences, Llc | Biaryl imidazole derivatives for regulating CYP17 |
JP6057698B2 (en) * | 2012-12-25 | 2017-01-11 | 東レ・ダウコーニング株式会社 | Method for producing imide group-containing organosilicon compound |
HUE049278T2 (en) * | 2014-08-15 | 2020-09-28 | Janssen Pharmaceuticals Inc | Pyrazoles |
HUE049277T2 (en) | 2014-08-15 | 2020-09-28 | Janssen Pharmaceuticals Inc | Triazoles as nr2b receptor inhibitors |
US10093613B2 (en) | 2015-04-21 | 2018-10-09 | Gtx, Inc. | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10806720B2 (en) | 2015-04-21 | 2020-10-20 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10654809B2 (en) | 2016-06-10 | 2020-05-19 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10865184B2 (en) | 2015-04-21 | 2020-12-15 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
DK3319963T3 (en) | 2015-07-09 | 2020-02-03 | Janssen Pharmaceutica Nv | SUBSTITUTED 4-AZA INDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS |
CN109071488B (en) | 2016-02-10 | 2021-08-13 | 詹森药业有限公司 | Substituted 1,2, 3-triazoles as NR 2B-selective NMDA modulators |
US10806719B2 (en) | 2016-06-10 | 2020-10-20 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
JP6956747B2 (en) | 2016-06-10 | 2021-11-02 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | Selective androgen receptor degradation agent (SARD) ligand and how to use it |
US11230523B2 (en) | 2016-06-10 | 2022-01-25 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
TW201819376A (en) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators |
EP3612522A4 (en) | 2017-04-18 | 2021-07-07 | Celgene Quanticel Research, Inc. | Therapeutic compounds |
CN107903213A (en) * | 2017-09-28 | 2018-04-13 | 山东大学 | 5 methyl 1H pyrazole derivatives and its preparation method and application |
US11008302B2 (en) | 2018-04-04 | 2021-05-18 | Janssen Pharmaceutica Nv | Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators |
CN108676001A (en) * | 2018-06-12 | 2018-10-19 | 江西师范大学 | A kind of 3- substitutions -5- isoxazolyls -4- substitution -1-1,2,3- triazol radical methane compounds |
WO2020249802A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators |
MX2021015508A (en) | 2019-06-14 | 2022-01-31 | Janssen Pharmaceutica Nv | Pyridine carbamates and their use as glun2b receptor modulators. |
BR112021023562A2 (en) | 2019-06-14 | 2022-01-04 | Janssen Pharmaceutica Nv | Pyrazine carbamates and their uses as glun2b receptor modulators |
JOP20210328A1 (en) | 2019-06-14 | 2023-01-30 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators |
EP3983073A1 (en) | 2019-06-14 | 2022-04-20 | Janssen Pharmaceutica NV | Substituted pyrazolo[4,3-b]pyridines and their use as glun2b receptor modulators |
SG11202112405VA (en) | 2019-06-14 | 2021-12-30 | Janssen Pharmaceutica Nv | Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators |
JP7288665B2 (en) * | 2019-08-02 | 2023-06-08 | 株式会社デ・ウエスタン・セラピテクス研究所 | Method for producing ethylanilinotoluenesulfonic acid derivative |
CN111499539B (en) * | 2020-04-20 | 2022-10-11 | 南昌大学 | Aryl cyanide synthesis method using aryl carboxylic acid as raw material |
TW202404963A (en) * | 2022-07-15 | 2024-02-01 | 韓商鐘根堂股份有限公司 | 1,3,4-oxadiazole triazole compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US401275A (en) * | 1889-04-09 | Wagon-tire | ||
AU7553198A (en) * | 1997-06-12 | 1998-12-30 | Sumitomo Pharmaceuticals Company, Limited | Pyrazole derivatives |
US20040229900A1 (en) * | 1999-06-16 | 2004-11-18 | Astrazeneca Ab | Bispidine compounds useful in the treatment of cardiac arrythmias |
SE0002603D0 (en) * | 2000-07-07 | 2000-07-07 | Astrazeneca Ab | New compounds |
ES2310202T3 (en) * | 2001-04-26 | 2009-01-01 | EISAI R&D MANAGEMENT CO., LTD. | CONDENSED CYCLING COMPOUND CONTAINING NITROGEN THAT HAS A PIRAZOLIL GROUP AS A SUBSTITUTING GROUP AND PHARMACEUTICAL COMPOSITION OF THE SAME. |
DE60226756D1 (en) * | 2001-10-04 | 2008-07-03 | Merck & Co Inc | METABOTROPIC GLUTAMATE RECEPTOR-5 HETEROARYLSUBSTITUTED TETRAZOL MODULATORS |
WO2003051315A2 (en) * | 2001-12-18 | 2003-06-26 | Merck & Co., Inc. | Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
ES2295441T3 (en) * | 2001-12-18 | 2008-04-16 | MERCK & CO., INC. | MODULATORS OF PIRAZOL HETEROARIL REPLACED 5 METABOTROPIC RECEIVER OF GLUTAMATE. |
CA2470612A1 (en) * | 2001-12-19 | 2003-07-03 | Merck & Co., Inc. | Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
AU2002351412B2 (en) * | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
CA2470519C (en) * | 2001-12-21 | 2009-11-17 | Merck & Co., Inc. | Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
CA2471754A1 (en) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Androgen receptor antagonist |
AU2003216581A1 (en) * | 2002-04-12 | 2003-10-27 | Pfizer Inc. | Pyrazole compounds as anti-inflammatory and analgesic agents |
US20040142978A1 (en) * | 2002-12-12 | 2004-07-22 | Pharmacia Corporation | Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
US20040127511A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
US20040127519A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
US7880001B2 (en) * | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
MXPA06012595A (en) * | 2004-04-29 | 2007-05-09 | Abbott Lab | Amino-tetrazoles analogues and methods of use. |
TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
MX2008012734A (en) * | 2006-04-04 | 2009-01-29 | Fibrogen Inc | Pyrrolo- and thiazolo-pyridine compounds as hif modulators. |
JP2007332053A (en) * | 2006-06-13 | 2007-12-27 | Takeda Chem Ind Ltd | Substituted pyrrole derivative |
AU2008262038A1 (en) * | 2007-06-08 | 2008-12-18 | AbbVie Deutschland GmbH & Co. KG | 5-heteroaryl substituted indazoles as kinase inhibitors |
PE20091653A1 (en) * | 2008-03-26 | 2009-11-14 | Takeda Pharmaceutical | SUBSTITUTE DERIVATIVES OF PIRAZOLE AND THEIR USE |
-
2008
- 2008-08-27 AU AU2008292429A patent/AU2008292429A1/en not_active Abandoned
- 2008-08-27 MX MX2010002266A patent/MX2010002266A/en not_active Application Discontinuation
- 2008-08-27 JP JP2009530148A patent/JPWO2009028543A1/en not_active Withdrawn
- 2008-08-27 KR KR1020107006668A patent/KR20100046275A/en not_active Application Discontinuation
- 2008-08-27 EA EA201070323A patent/EA201070323A1/en unknown
- 2008-08-27 CL CL2008002521A patent/CL2008002521A1/en unknown
- 2008-08-27 CA CA2697663A patent/CA2697663A1/en not_active Abandoned
- 2008-08-27 PE PE2008001451A patent/PE20090610A1/en not_active Application Discontinuation
- 2008-08-27 TW TW097132642A patent/TW200913993A/en unknown
- 2008-08-27 US US12/675,748 patent/US20100227846A1/en not_active Abandoned
- 2008-08-27 AR ARP080103710A patent/AR068813A1/en unknown
- 2008-08-27 CN CN200880114151A patent/CN101842357A/en active Pending
- 2008-08-27 BR BRPI0816095-3A2A patent/BRPI0816095A2/en not_active Application Discontinuation
- 2008-08-27 WO PCT/JP2008/065286 patent/WO2009028543A1/en active Application Filing
- 2008-08-27 EP EP08828418A patent/EP2194045A4/en not_active Withdrawn
- 2008-08-27 US US12/199,008 patent/US20090270359A1/en not_active Abandoned
-
2010
- 2010-02-23 TN TNP2010000091A patent/TN2010000091A1/en unknown
- 2010-02-26 DO DO2010000068A patent/DOP2010000068A/en unknown
- 2010-03-26 CO CO10036555A patent/CO6190530A2/en not_active Application Discontinuation
- 2010-03-26 MA MA32720A patent/MA31714B1/en unknown
- 2010-03-30 EC EC2010010060A patent/ECSP10010060A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20090270359A1 (en) | 2009-10-29 |
CO6190530A2 (en) | 2010-08-19 |
PE20090610A1 (en) | 2009-06-11 |
DOP2010000068A (en) | 2010-03-15 |
US20100227846A1 (en) | 2010-09-09 |
MX2010002266A (en) | 2010-03-25 |
CN101842357A (en) | 2010-09-22 |
TN2010000091A1 (en) | 2011-09-26 |
WO2009028543A1 (en) | 2009-03-05 |
JPWO2009028543A1 (en) | 2010-12-02 |
KR20100046275A (en) | 2010-05-06 |
EP2194045A1 (en) | 2010-06-09 |
AU2008292429A1 (en) | 2009-03-05 |
BRPI0816095A2 (en) | 2015-03-03 |
TW200913993A (en) | 2009-04-01 |
MA31714B1 (en) | 2010-09-01 |
ECSP10010060A (en) | 2010-04-30 |
CL2008002521A1 (en) | 2009-11-20 |
EP2194045A4 (en) | 2011-09-21 |
EA201070323A1 (en) | 2010-10-29 |
CA2697663A1 (en) | 2009-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR068813A1 (en) | DERIVATIVES OF PIRAZOL REPLACED AS ANTAGONISTS OF THE ANDROGEN RECEIVER (AR), A PHARMACEUTICAL AGENT THAT UNDERSTANDS AND USES THEMSELVES IN THE TREATMENT OF PROSTATE CANCER | |
ECSP088113A (en) | NEW DERIVATIVES OF PIRAZINA | |
CR9459A (en) | BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME | |
CO6321282A2 (en) | PIPERIDINYLINDOL DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA | |
AR072166A1 (en) | PIPERIDINE DERIVATIVE AND ITS USE AS A SUPERIOR RENINA INHIBITOR | |
ES2662444T3 (en) | Pyridine derivative | |
ATE508747T1 (en) | C-KIT KINASE INHIBITORS | |
DK2134691T3 (en) | QUINOLINONDERIVATIVES AS PARP AND TANK INHIBITORS | |
AR063028A1 (en) | HETEROCICLIC DERIVATIVES OF PIRIDIN-2-CARBOXAMIDE GLUCOKINASE ACTIVATORS, USEFUL FOR THE TREATMENT OF DIABETES AND OBESITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
UY30498A1 (en) | NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
NZ579928A (en) | Fluorinated derivatives of deferiprone | |
CY1111628T1 (en) | Substituted bicyclactam compounds | |
CR11220A (en) | PIRIMIDINE DERIVATIVES 934 | |
AR072016A1 (en) | ISOXAZOL DERIVATIVES THAT WORK AS POTENTIALS OF GLUTAMATE RECEIVERS | |
UA109525C2 (en) | ALKYLAMIDE COMPOUND AND ITS APPLICATIONS | |
AR071069A1 (en) | REPLACED DERIVATIVES OF PIRAZOL AND ITS USE FOR THE PREVENTION OR TREATMENT OF CANCER | |
DOP2010000226A (en) | TRICICLIC COMPOUNDS THAT HAVE ANTAGONIST ACTIVITY OF CORTICOTROPINE RELEASE FACTOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
CU23761B7 (en) | NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CO6321269A2 (en) | BENZOXAZINONE DERIVATIVES ACTING AS BETA 2 ADRENERGIC RECEIVER AGONISTS FOR THE TREATMENT OF RESPIRATORY DISORDERS | |
CR20110381A (en) | CCR2 4-AZETIDINIL-1-HETEROARIL-CICLOHEXANOL ANTAGONISTS | |
AR066962A1 (en) | FUSED HETEROCICLIC COMPOUND | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
AR063805A1 (en) | TRIAZOL DERIVATIVES REPLACED AS KSP INHIBITORS. PHARMACEUTICAL COMPOSITIONS. | |
MX2009010945A (en) | 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles, and use thereof as herbicides. | |
ECSP024375A (en) | DERIVATIVES OF 2-AMINOTIAZOLINE AND ITS USE AS INHIBITORS OF NON-SYNTHEASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |